Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu

Clinical Research

What’s the Role of Myelin Oligodendrocyte Glycoprotein in NMO?

MOG structure
Researchers are working to refine a cell-based assay that more accurately identifies antibodies for myelin oligodendrocyte glycoprotein (MOG) in the serum of patients with neuromyelitis optica spectrum disorders. Some think that anti-MOG-positive patients may even represent a distinct demyelinating disease.
Scientists understand neuromyelitis optica spectrum disorders far better now than when they were...
Clinical Research

The Paradox of Daclizumab

Dr. Bibiana Bielekova
Phase 3 results show that daclizumab reduces disease activity in relapsing-remitting multiple sclerosis by half compared with interferon, as measured by brain imaging, with skin and other side effects. The drug works in surprising ways that are revealing new details about the pathogenesis of MS.
Three might be the lucky number for daclizumab, an investigational drug for relapsing-remitting multiple sclerosis with...
Clinical Research, Drug Development, Laboratory Research, Meetings


The meeting's final day featured late breakers, the closing lecture, and two masterful summaries of research highlights
Last day of #ACTRIMS #ECTRIMS 2day! L8 breaking news & closing plenary-awards...
Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People


Subscribe to RSS - Clinical Research